Fig. 4

Evaluation of the constructed signature. (A) The Kaplan-Meier survival analysis demonstrats that patients with higher risk scores had worse prognoses (P < 0.001). (B) The AUC of the 1-year survival and 5-year survival curves indicated that the signature had a good predictive capacity. (C) The survival analysis of miRNAs in the signature shows that high expression levels of miR-223-3p and low expression levels of miR-200a-5p and miR-500a-3p were associated with poor prognoses (P < 0.05)